Early glycoxidation damage in brains from Down's syndrome.
about
Alzheimer Disease and Oxidative StressMulti-Target Directed Donepezil-Like Ligands for Alzheimer's DiseaseThe role of lipid peroxidation in neurological disordersBlood markers of oxidative stress in Alzheimer's diseaseProtein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part IV)Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Alzheimer's Disease in Down Syndrome.Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment.Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies.Down syndrome and Alzheimer's disease: a link between development and aging.Involvement of Maillard reactions in Alzheimer disease.Identification of a DNA methylation signature in blood cells from persons with Down Syndrome.The role of environmental exposures in neurodegeneration and neurodegenerative diseases.Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia.Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.Antioxidants in Down syndrome.Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.Advanced glycation and lipoxidation end products--amplifiers of inflammation: the role of food.Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway.Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain.The identification of protein biomarkers for oxidative stress in Down syndrome.4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studiesMass spectrometry and redox proteomics: applications in disease.Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-β in amplifying neuronal damage in Alzheimer's disease: three partners in crime.A unifying hypothesis of Alzheimer's disease. III. Risk factors.Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome.
P2860
Q24801475-6B267BCF-FD48-470E-B85D-751A697A9C8DQ26744105-7AAD8FA4-9695-4DF0-B7E9-96C0217F9ED2Q26829767-F8A86C5E-33EB-4D13-B7EA-E5DB58CA6258Q27021625-1DA4FFD3-1BEC-4E3C-80DB-A9D6E8DC4484Q28183718-A050790A-D9B4-46E6-B867-3C869C7BA56CQ30446460-6EEAD9BE-6909-4CE8-A3F5-C1A1EF466E3EQ30857550-4D1C6B86-69D5-42F5-98F8-4D28EAA4102EQ33740552-63B89F0F-E7CE-44C5-B51A-B16249FC59C1Q34073939-9A8B3FAE-B534-4E4D-A83F-C41F7F2CD99DQ34366691-AC8B01EF-547A-4EEB-9009-F264C0A70C34Q35164047-2A69C6F7-23F7-463D-8A27-D0B639247EB2Q35177595-E397282F-3593-4C7F-9E1F-360E906B1C99Q35551001-59196E42-6F2C-4B65-9F10-4F98C093C7DEQ35606429-3AB8CF69-2100-45BD-89B6-5653454EB0F9Q35677159-D5FBCA92-D9ED-4DC5-A9E1-AA9BDD39C211Q36126681-03DE73B0-AF27-49E2-B247-82EB69C3919CQ36390685-5855936B-169E-4570-AB59-09B40B1BF1F4Q36915810-302522DA-61BA-4B2F-A9A8-F3F5D8F36FF6Q37102001-23B0E7AD-29F0-4BE5-836D-147215DF8D0CQ37287738-42315590-493A-4DE7-A0C5-1B912A08D6A4Q37613081-FF7F38A4-BE22-45BE-A79F-9E2889B59F06Q37912195-D97A83DA-65CC-4ADF-BCF3-800518742E0DQ37960537-7DA2CBC6-6E8D-478D-87E5-F24ED644418EQ38220377-08F7DCE8-0C53-4CCD-850F-810E417EE7C9Q39601921-BB59F017-3E3D-4A66-A6FB-5851E8CBE2AEQ48458709-D196B0ED-4AB3-4670-83C3-AE67632979EDQ53233049-EEA4358D-0BC3-442A-AD6F-7E733500631F
P2860
Early glycoxidation damage in brains from Down's syndrome.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Early glycoxidation damage in brains from Down's syndrome.
@en
Early glycoxidation damage in brains from Down's syndrome.
@nl
type
label
Early glycoxidation damage in brains from Down's syndrome.
@en
Early glycoxidation damage in brains from Down's syndrome.
@nl
prefLabel
Early glycoxidation damage in brains from Down's syndrome.
@en
Early glycoxidation damage in brains from Down's syndrome.
@nl
P2093
P356
P1476
Early glycoxidation damage in brains from Down's syndrome
@en
P2093
F Dagna-Bricarelli
N Traverso
S Garibaldi
P304
P356
10.1006/BBRC.1998.8186
P407
P577
1998-02-01T00:00:00Z